Anti-Vascular Endothelial Growth Factor Therapy for Complications of Diabetic Retinopathy-From Treatment to Prevention?

JAMA Ophthalmol. 2023 Mar 1;141(3):223-225. doi: 10.1001/jamaophthalmol.2023.0496.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Diabetes Mellitus*
  • Diabetic Retinopathy* / drug therapy
  • Diabetic Retinopathy* / metabolism
  • Diabetic Retinopathy* / prevention & control
  • Endothelial Growth Factors / therapeutic use
  • Humans
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Endothelial Growth Factors
  • Vascular Endothelial Growth Factor A
  • Angiogenesis Inhibitors